According to the new market research report “Centesis Catheters Market by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region – Global Forecast to 2025”, published by MarketsandMarkets™, the Centesis Catheters Market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, at a CAGR of 6.8%.
Growth in the global centesis catheters market can be attributed to factors such as the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases.
Small-bore centesis catheters segment accounted for the largest share of the centesis catheters market, by type, in 2018
Based on type, the centesis catheters market is segmented into small-bore and large-bore centesis catheters. The small-bore centesis catheters segment accounted for the largest share of this market in 2018. This can be attributed to the wide availability of small-bore centesis catheters, growing number of target procedures that require small-bore centesis catheters, increasing evidence of the efficacy and safety of small-bore centesis catheters over large-bore centesis catheters, and their higher adoption in diagnostic centesis procedures.
Paracentesis procedures segment accounted for the largest share of the centesis catheters market, by procedure, in 2018
Based on procedure, the centesis catheters market is segmented into paracentesis, thoracentesis, arthrocentesis, amniocentesis, and other procedures. The paracentesis segment accounted for the largest share of this market in 2018. The rising incidence of target conditions such as gastrointestinal malignancies, liver cirrhosis, cystic fibrosis, intestinal tuberculosis, chronic liver failure, formation of cysts in the peritoneal cavity, and serious forms of hepatitis is expected to drive the growth of this market segment in the coming years.
Hospitals were the largest end users of centesis catheters in 2018
Based on end user, the global centesis catheters market has been segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for the largest share of the market in 2018. This is because the majority of centesis procedures are performed in hospitals owing to the risks involved in these procedures and the higher patient preference for hospital-based care for target disease conditions, such as gastrointestinal malignancies, liver cirrhosis, cystic fibrosis, intestinal tuberculosis, chronic liver failure, peritonitis, and pleural effusion.
Asia Pacific is the fastest-growing regional market for centesis catheters
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the presence of a large patient pool, increasing incidence and prevalence of target diseases, improving healthcare infrastructure in Asian countries, and the favorable government initiatives for improving access to healthcare.
The key players operating in the global centesis catheters market are AngioDynamics, Inc. (US), ARGON MEDICAL (US), Avanos Medical Devices (US), Axiom Medical, Inc. (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (US), Blue Neem Medical Devices Pvt. Ltd. (India), Boston Scientific Corporation (US), Canadian Hospital Specialties Ltd. (Canada), Cardinal Health (US), Cook Medical (US), Galt Medical Corp. (US), Guangzhou Leadgem Medical Device Co., Ltd. (China), KM Medical (US), Medical Components, Inc. (US), Medtronic (Ireland), Merit Medical Systems (US), Mermaid Medical A/S (Denmark), MoFlo Medical Technology Co., Ltd. (China), Neuromedex GmbH (Germany), Ningbo Honde Medical Instruments Co., Ltd. (China), PFM Medical, Inc. (US), Polymedicure (India), REDAX (Italy), Rocket Medical plc. (UK), Romsons (India), Smiths Medical (US), Teleflex Incorporated (US), UreSil, LLC (US), and Utah Medical Products, Inc. (US).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly